Skip to main content
Erschienen in: Diabetologia 11/2012

01.11.2012 | Article

Erythrocyte trans-fatty acids, type 2 diabetes and cardiovascular risk factors in middle-aged and older Chinese individuals

verfasst von: D. X. Yu, Q. Sun, X. W. Ye, A. Pan, G. Zong, Y. H. Zhou, H. X. Li, F. B. Hu, X. Lin

Erschienen in: Diabetologia | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Few data are available about intakes and food sources of trans-fatty acids (TFAs) or their associations with cardiometabolic outcomes in Asian people who consume a prudent diet but are experiencing rapid nutritional transitions. We aimed to investigate the relationships between TFA biomarkers and type 2 diabetes and cardiovascular risk factors in Chinese individuals.

Methods

Erythrocyte fatty acids were measured by gas chromatography among 3,107 men and women (50–70 years) recruited from urban and rural areas in Beijing and Shanghai, China.

Results

Total trans-18:1 and two trans-18:2 isomers were detected and accounted for 0.37% of the total fatty acids in the erythrocytes. Concentrations of TFAs were higher in women than men, and in urban than rural residents. Of the TFAs, trans-18:1, but not trans-18:2, showed a modest association with dairy consumption (β = 0.27), but not with other foods. After adjustment for BMI, social-demographic, lifestyle and dietary factors and other TFAs, erythrocyte trans-18:1 was shown to be associated with a lower risk of type 2 diabetes (OR comparing extreme [first and fourth] quartiles 0.68, 95% CI 0.48, 0.97, p trend = 0.02), as well as 20–50% lower odds of central obesity, dyslipidaemia, hyperglycaemia, insulin resistance and chronic inflammation. In contrast, trans-18:2 fatty acids were positively associated with high triacylglycerol (p trend < 0.001) and LDL-cholesterol (p trend = 0.03) levels, but not with diabetes and other cardiometabolic risk factors.

Conclusions/interpretation

Among middle-aged and older Chinese individuals with overall low erythrocyte TFAs levels, trans-18:1 might serve as a marker of dairy intake. Higher trans-18:1 levels were associated with a lower risk of type 2 diabetes, whereas higher trans-18:2 levels were associated with dyslipidaemia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hu FB, Liu Y, Willett WC (2011) Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev 12:552–559PubMedCrossRef Hu FB, Liu Y, Willett WC (2011) Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev 12:552–559PubMedCrossRef
2.
Zurück zum Zitat Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31:177–188CrossRef Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31:177–188CrossRef
3.
Zurück zum Zitat Micha R, Mozaffarian D (2009) Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 5:335–344PubMedCrossRef Micha R, Mozaffarian D (2009) Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 5:335–344PubMedCrossRef
4.
Zurück zum Zitat Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601–1613PubMedCrossRef Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601–1613PubMedCrossRef
5.
Zurück zum Zitat Mozaffarian D, Aro A, Willett WC (2009) Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63(Suppl 2):S5–S21PubMedCrossRef Mozaffarian D, Aro A, Willett WC (2009) Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63(Suppl 2):S5–S21PubMedCrossRef
6.
Zurück zum Zitat Motard-Bélanger A, Charest A, Grenier G et al (2008) Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87:593–599PubMed Motard-Bélanger A, Charest A, Grenier G et al (2008) Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87:593–599PubMed
7.
Zurück zum Zitat Chardigny JM, Destaillats F, Malpuech-Brugere C et al (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87:558–566PubMed Chardigny JM, Destaillats F, Malpuech-Brugere C et al (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87:558–566PubMed
8.
Zurück zum Zitat van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25:417–424PubMedCrossRef van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25:417–424PubMedCrossRef
9.
Zurück zum Zitat Salmeron J, Hu FB, Manson JE et al (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73:1019–1026PubMed Salmeron J, Hu FB, Manson JE et al (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73:1019–1026PubMed
10.
Zurück zum Zitat Morio B, Tardy AL, Chardigny JM, Malpuech-Brugere C (2011) Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases. Nutr Res Rev 24:111–117CrossRef Morio B, Tardy AL, Chardigny JM, Malpuech-Brugere C (2011) Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases. Nutr Res Rev 24:111–117CrossRef
11.
Zurück zum Zitat Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM (2006) Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 83:237–243PubMed Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM (2006) Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 83:237–243PubMed
12.
Zurück zum Zitat Lemaitre RN, King IB, Mozaffarian D et al (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114:209–215PubMedCrossRef Lemaitre RN, King IB, Mozaffarian D et al (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114:209–215PubMedCrossRef
13.
Zurück zum Zitat Mozaffarian D, Cao H, King IB et al (2010) Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 153:790–799PubMed Mozaffarian D, Cao H, King IB et al (2010) Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 153:790–799PubMed
14.
Zurück zum Zitat Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X (2007) Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49:1798–1805PubMedCrossRef Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X (2007) Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49:1798–1805PubMedCrossRef
15.
Zurück zum Zitat Yu Z, Ye X, Wang J et al (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older Chinese people. Circulation 119:2969–2977PubMedCrossRef Yu Z, Ye X, Wang J et al (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older Chinese people. Circulation 119:2969–2977PubMedCrossRef
16.
Zurück zum Zitat Zhai F, Yang X (eds) (2006) The nutrition and health status of the Chinese people 2002: diet and nutrients intake. People’s Medical Publishing House, Beijing Zhai F, Yang X (eds) (2006) The nutrition and health status of the Chinese people 2002: diet and nutrients intake. People’s Medical Publishing House, Beijing
17.
Zurück zum Zitat Zhao W, Hasegawa K, Chen J (2002) The use of food-frequency questionnaires for various purposes in China. Public Health Nutr 5(6A):829–833PubMedCrossRef Zhao W, Hasegawa K, Chen J (2002) The use of food-frequency questionnaires for various purposes in China. Public Health Nutr 5(6A):829–833PubMedCrossRef
18.
Zurück zum Zitat Shi Z, Hu X, Yuan B et al (2006) Association between dietary patterns and anemia in adults from Jiangsu Province in Eastern China. Br J Nutr 96:906–912PubMedCrossRef Shi Z, Hu X, Yuan B et al (2006) Association between dietary patterns and anemia in adults from Jiangsu Province in Eastern China. Br J Nutr 96:906–912PubMedCrossRef
19.
Zurück zum Zitat Yang Y (ed) (2005) Chinese food composition table 2004. Peking University Medical Press, Beijing Yang Y (ed) (2005) Chinese food composition table 2004. Peking University Medical Press, Beijing
20.
Zurück zum Zitat Atkinson FS, Foster-Powell K, Brand-Miller JC (2008) International tables of glycemic index and glycemic load values: 2008. Diabetes Care 31:2281–2283PubMedCrossRef Atkinson FS, Foster-Powell K, Brand-Miller JC (2008) International tables of glycemic index and glycemic load values: 2008. Diabetes Care 31:2281–2283PubMedCrossRef
21.
Zurück zum Zitat American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42–S47CrossRef American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42–S47CrossRef
22.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef
23.
Zurück zum Zitat Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular diseases: application to clinical and public health practice. Circulation 107:499–511PubMedCrossRef Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular diseases: application to clinical and public health practice. Circulation 107:499–511PubMedCrossRef
24.
Zurück zum Zitat Sun Q, Ma J, Campos H, Hankinson SE, Hu FB (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86:74–81PubMed Sun Q, Ma J, Campos H, Hankinson SE, Hu FB (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86:74–81PubMed
25.
Zurück zum Zitat Baylin A, Kim MK, Donovan-Palmer A et al (2005) Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 162:373–381PubMedCrossRef Baylin A, Kim MK, Donovan-Palmer A et al (2005) Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 162:373–381PubMedCrossRef
26.
Zurück zum Zitat Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S, discussion 1229S-1231SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S, discussion 1229S-1231SPubMed
27.
Zurück zum Zitat Sun Q, Ma J, Campos H et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115:1858–1865PubMedCrossRef Sun Q, Ma J, Campos H et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115:1858–1865PubMedCrossRef
28.
Zurück zum Zitat Micha R, King IB, Lemaitre RN et al (2010) Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 91:883–893PubMedCrossRef Micha R, King IB, Lemaitre RN et al (2010) Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 91:883–893PubMedCrossRef
29.
Zurück zum Zitat Sun Q, Ma J, Campos H, Hu FB (2007) Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart diseased. Am J Clin Nutr 86:929–937PubMed Sun Q, Ma J, Campos H, Hu FB (2007) Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart diseased. Am J Clin Nutr 86:929–937PubMed
30.
Zurück zum Zitat No authors listed (1995) Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 62: 655S-708S; discussion 518–626 No authors listed (1995) Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 62: 655S-708S; discussion 518–626
31.
Zurück zum Zitat Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y (2008) Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 87:1914–1925PubMed Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y (2008) Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 87:1914–1925PubMed
32.
Zurück zum Zitat Goldbohm RA, Chorus AM, Galindo Garre F, Schouten LJ, van den Brandt PA (2011) Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 93:615–627PubMedCrossRef Goldbohm RA, Chorus AM, Galindo Garre F, Schouten LJ, van den Brandt PA (2011) Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 93:615–627PubMedCrossRef
33.
Zurück zum Zitat Smedman AE, Gustafsson IB, Berglund LG, Vessby BO (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69:22–29PubMed Smedman AE, Gustafsson IB, Berglund LG, Vessby BO (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69:22–29PubMed
34.
Zurück zum Zitat Wolk A, Furuheim M, Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131:828–833PubMed Wolk A, Furuheim M, Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131:828–833PubMed
35.
Zurück zum Zitat Willett W (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef Willett W (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef
36.
Zurück zum Zitat Elwood PC, Pickering JE, Givens DI, Gallacher JE (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45:925–939PubMedCrossRef Elwood PC, Pickering JE, Givens DI, Gallacher JE (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45:925–939PubMedCrossRef
37.
Zurück zum Zitat Crichton GE, Bryan J, Buckley J, Murphy KJ (2011) Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev 12:e190–e201PubMedCrossRef Crichton GE, Bryan J, Buckley J, Murphy KJ (2011) Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev 12:e190–e201PubMedCrossRef
38.
Zurück zum Zitat Villegas R, Gao YT, Dai Q et al (2009) Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women’s Health Study. Am J Clin Nutr 89:1059–1067PubMedCrossRef Villegas R, Gao YT, Dai Q et al (2009) Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women’s Health Study. Am J Clin Nutr 89:1059–1067PubMedCrossRef
39.
Zurück zum Zitat Wang Y, Lu J, Ruth MR et al (2008) Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. J Nutr 138:2117–2122PubMedCrossRef Wang Y, Lu J, Ruth MR et al (2008) Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. J Nutr 138:2117–2122PubMedCrossRef
40.
Zurück zum Zitat Bassett CM, Edel AL, Patenaude AF et al (2010) Dietary vaccenic acid has antiatherogenic effects in LDLr−/− mice. J Nutr 140:18–24PubMedCrossRef Bassett CM, Edel AL, Patenaude AF et al (2010) Dietary vaccenic acid has antiatherogenic effects in LDLr−/− mice. J Nutr 140:18–24PubMedCrossRef
41.
Zurück zum Zitat Smit LA, Willett WC, Campos H (2010) Trans-fatty acid isomers in adipose tissue have divergent associations with adiposity in humans. Lipids 45:693–700PubMedCrossRef Smit LA, Willett WC, Campos H (2010) Trans-fatty acid isomers in adipose tissue have divergent associations with adiposity in humans. Lipids 45:693–700PubMedCrossRef
42.
Zurück zum Zitat Thompson AK, Minihane AM, Williams CM (2011) Trans fatty acids and weight gain. Int J Obes (Lond) 35:315–324CrossRef Thompson AK, Minihane AM, Williams CM (2011) Trans fatty acids and weight gain. Int J Obes (Lond) 35:315–324CrossRef
43.
Zurück zum Zitat Sébédio JL, Chardigny JM, Malpuech-Brugère C, Erickson MD (2006) Deep frying chemistry. Physiological effects of trans and cyclic fatty acids: Nutrition and Practical Applications. AOCS Press, Urbana, pp 205–228 Sébédio JL, Chardigny JM, Malpuech-Brugère C, Erickson MD (2006) Deep frying chemistry. Physiological effects of trans and cyclic fatty acids: Nutrition and Practical Applications. AOCS Press, Urbana, pp 205–228
Metadaten
Titel
Erythrocyte trans-fatty acids, type 2 diabetes and cardiovascular risk factors in middle-aged and older Chinese individuals
verfasst von
D. X. Yu
Q. Sun
X. W. Ye
A. Pan
G. Zong
Y. H. Zhou
H. X. Li
F. B. Hu
X. Lin
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 11/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2674-2

Weitere Artikel der Ausgabe 11/2012

Diabetologia 11/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.